These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25765541)

  • 1. Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice.
    Hata R; Izukuri K; Kato Y; Sasaki S; Mukaida N; Maehata Y; Miyamoto C; Akasaka T; Yang X; Nagashima Y; Takeda K; Kiyono T; Taniguchi M
    Sci Rep; 2015 Mar; 5():9083. PubMed ID: 25765541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma cell transplants. [corrected].
    Izukuri K; Suzuki K; Yajima N; Ozawa S; Ito S; Kubota E; Hata R
    Transgenic Res; 2010 Dec; 19(6):1109-17. PubMed ID: 20333465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of tumour-suppressing chemokine BRAK/CXCL14 reduces cell migration rate of HSC-3 tongue carcinoma cells and stimulates attachment to collagen and formation of elongated focal adhesions in vitro.
    Sato K; Ozawa S; Izukuri K; Kato Y; Hata R
    Cell Biol Int; 2010 Apr; 34(5):513-22. PubMed ID: 20067447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of pulmonary tumour metastasis in mice by recombinant human interleukin-2: role of asialo GM1-positive cells.
    Hinuma S; Naruo K; Ootsu K; Houkan T; Shiho O; Tsukamoto K
    Immunology; 1987 Feb; 60(2):173-9. PubMed ID: 3493209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
    Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-X-C Motif Chemokine Ligand 14 is a Unique Multifunctional Regulator of Tumor Progression.
    Yang XY; Ozawa S; Kato Y; Maehata Y; Izukuri K; Ikoma T; Kanamori K; Akasaka T; Suzuki K; Iwabuchi H; Kurata SI; Katoh I; Sakurai T; Kiyono T; Hata RI
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31014014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CXCL14 and its anticancer role in breast cancer.
    Gu XL; Ou ZL; Lin FJ; Yang XL; Luo JM; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2012 Oct; 135(3):725-35. PubMed ID: 22910931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDX2 enhances natural killer cell-mediated immunotherapy against head and neck squamous cell carcinoma through up-regulating CXCL14.
    Wang H; Nan S; Wang Y; Xu C
    J Cell Mol Med; 2021 May; 25(10):4596-4607. PubMed ID: 33733587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immune responses involving natural killer and natural killer T cells promote liver regeneration after partial hepatectomy in mice.
    Hosoya S; Ikejima K; Takeda K; Arai K; Ishikawa S; Yamagata H; Aoyama T; Kon K; Yamashina S; Watanabe S
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(3):G293-9. PubMed ID: 23086918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of CXC chemokine ligand 14 exacerbates collagen-induced arthritis.
    Chen L; Guo L; Tian J; He H; Marinova E; Zhang P; Zheng B; Han S
    J Immunol; 2010 Apr; 184(8):4455-9. PubMed ID: 20212097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic defense system by cooperative natural effectors against metastasis of B16 melanoma cells in H-2-associated control: different behavior of H-2+ and H-2- cells in metastatic processes.
    Kawano Y; Taniguchi K; Toshitani A; Nomoto K
    J Immunol; 1986 Jun; 136(12):4729-34. PubMed ID: 3711664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AsGM1+ NK cells prevent metastasis of invading LD-MCA-38 tumor cells in the nude mouse.
    Volpe CM; Mehta N; Kim U; Hordines J; Doerr RJ; Cohen SA
    J Surg Res; 1999 Jun; 84(2):157-61. PubMed ID: 10357913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy.
    Starnes T; Rasila KK; Robertson MJ; Brahmi Z; Dahl R; Christopherson K; Hromas R
    Exp Hematol; 2006 Aug; 34(8):1101-5. PubMed ID: 16863917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
    Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
    J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
    Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
    Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of proximal promoter of gene for human BRAK/CXCL14, a tumor-suppressing chemokine.
    Komori R; Ozawa S; Kato Y; Shinji H; Kimoto S; Hata R
    Biomed Res; 2010 Apr; 31(2):123-31. PubMed ID: 20460740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a chemokine BRAK/CXCL14 in oral floor carcinoma cells reduces the settlement rate of the cells and suppresses their proliferation in vivo.
    Ito S; Ozawa S; Ikoma T; Yajima N; Kiyono T; Hata R
    Biomed Res; 2010 Jun; 31(3):199-206. PubMed ID: 20622470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic deletion of Cxcl14 in mice alters uterine NK cells.
    Cao Q; Chen H; Deng Z; Yue J; Chen Q; Cao Y; Ning L; Lei X; Duan E
    Biochem Biophys Res Commun; 2013 Jun; 435(4):664-70. PubMed ID: 23688424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cells rapidly remove B16F10 tumor cells in a perforin and interferon-gamma independent manner in vivo.
    Grundy MA; Zhang T; Sentman CL
    Cancer Immunol Immunother; 2007 Aug; 56(8):1153-61. PubMed ID: 17160409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-18 and the costimulatory molecule B7-1 have a synergistic anti-tumor effect on murine melanoma; implication of combined immunotherapy for poorly immunogenic malignancy.
    Cho D; Kim TG; Lee W; Hwang YI; Cho HI; Han H; Kwon O; Kim D; Park H; Houh D
    J Invest Dermatol; 2000 May; 114(5):928-34. PubMed ID: 10771473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.